These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18433947)

  • 1. Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.
    Ishikawa T; Widman DG; Bourne N; Konishi E; Mason PW
    Vaccine; 2008 May; 26(22):2772-81. PubMed ID: 18433947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.
    Widman DG; Ishikawa T; Fayzulin R; Bourne N; Mason PW
    Vaccine; 2008 May; 26(22):2762-71. PubMed ID: 18423946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.
    Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW
    Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
    Lim CK; Takasaki T; Kotaki A; Kurane I
    Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters.
    Widman DG; Ishikawa T; Winkelmann ER; Infante E; Bourne N; Mason PW
    Vaccine; 2009 Sep; 27(41):5550-3. PubMed ID: 19635608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus.
    Yamshchikov G; Borisevich V; Kwok CW; Nistler R; Kohlmeier J; Seregin A; Chaporgina E; Benedict S; Yamshchikov V
    Vaccine; 2005 Sep; 23(39):4785-92. PubMed ID: 15939510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
    Pugachev KV; Mason PW; Shope RE; Frey TK
    Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
    Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
    Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.
    Suzuki R; Winkelmann ER; Mason PW
    J Virol; 2009 Feb; 83(4):1870-80. PubMed ID: 19073745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques.
    Goverdhan MK; Kulkarni AB; Gupta AK; Tupe CD; Rodrigues JJ
    Acta Virol; 1992 May; 36(3):277-83. PubMed ID: 1360756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
    Li SH; Li XF; Zhao H; Jiang T; Deng YQ; Yu XD; Zhu QY; Qin ED; Qin CF
    Immunol Lett; 2011 Aug; 138(2):156-60. PubMed ID: 21515306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
    Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
    Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.